BY

SEQENSgroup

Alganelle is an innovative biotechnology company with a disruptive technology at the forefront of microalgae synthetic biology, providing a safer, high quality raw material obtained from sustainable processes that respect the environment and biodiversity. The company is led by its inspirational CEO, Dr Ghislaine Tissot-Lécuelle.

Supported financially and technically by Seqens since 2016, Alganelle has just reached an important milestone in its development with the announcement of a strong partnership with Sederma, one of the world leaders in bioactive ingredients for the cosmetics industry.

“This partnership marks a key step in the commercial development of Alganelle and I would like to congratulate the teams for the work they have accomplished. Seqens is confident that Alganelle will be able to impose its technology and unique know-how on other industrial demonstrators in the near future.” says Pierre Luzeau, President of SEQENS.

DISCOVER OUR NEWS

Learn more